Global burden of recurrent vulvovaginal candidiasis: a systematic review

David W Denning; Matthew Kneale; Jack D Sobel; Riina Rautemaa-Richardson

doi:10.1016/s1473-3099(18)30103-8

journal article Nov 01, 2018

Global burden of recurrent vulvovaginal candidiasis: a systematic review

David W Denning

Matthew Kneale Jack D Sobel Riina Rautemaa-Richardson

The Lancet Infectious Diseases Vol. 18 No. 11 pp. e339-e347 · Elsevier BV

View at Publisher Save 10.1016/s1473-3099(18)30103-8

Topics

No keywords indexed for this article. Browse by subject →

References

53

[1]

Vulvovaginal candidosis

Jack D Sobel

The Lancet 2007 10.1016/s0140-6736(07)60917-9

[2]

Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors

Bruna Gonçalves, Carina Ferreira, Carlos Tiago Alves et al.

Critical Reviews in Microbiology 2015 10.3109/1040841x.2015.1091805

[3]

Ilkit "The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: a mycological perspective" Crit Rev Microbiol (2011) 10.3109/1040841x.2011.576332

[4]

Fischer "Chronic vulvovaginal candidiasis: what we know and what we have yet to learn" Australas J Dermatol (2012) 10.1111/j.1440-0960.2011.00860.x

[5]

Hong "Vulvovaginal candidiasis as a chronic disease: diagnostic criteria and definition" J Low Genit Tract Dis (2014) 10.1097/lgt.0b013e318287aced

[6]

Aballéa "Subjective health status and health-related quality of life among women with recurrent vulvovaginal candidosis (RVVC) in Europe and the USA" Health Qual Life Outcomes (2013) 10.1186/1477-7525-11-169

[7]

Chapple "Vaginal thrush: perceptions and experiences of women of south Asian descent" Health Educ Res (2001) 10.1093/her/16.1.9

[8]

Irving "Psychological factors associated with recurrent vaginal candidiasis: a preliminary study" Sex Transm Infect (1998) 10.1136/sti.74.5.334

[9]

Powell "Vaginal thrush: quality of life and treatments" Br J Nurs (2010) 10.12968/bjon.2010.19.17.78559

[10]

Sobel "Recurrent vulvovaginal candidiasis" Am J Obstet Gynecol (2016) 10.1016/j.ajog.2015.06.067

[11]

Ehrström "Signs of chronic stress in women with recurrent candida vulvovaginitis" Am J Obstet Gynecol (2005) 10.1016/j.ajog.2005.03.068

[12]

Corsello "An epidemiological survey of vulvovaginal candidiasis in Italy" Eur J Obstet Gynecol Reprod Biol (2003) 10.1016/s0301-2115(03)00096-4

[13]

Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections

Chao Tian, Bethann S. Hromatka, Amy K. Kiefer et al.

Nature Communications 2017 10.1038/s41467-017-00257-5

[14]

Jaeger "Association of a variable number tandem repeat in the NLRP3 gene in women with susceptibility to RVVC" Eur J Clin Microbiol Infect Dis (2016) 10.1007/s10096-016-2600-5

[15]

Marchaim "Fluconazole-resistant Candida albicans vulvovaginitis" Obstet Gynecol (2012) 10.1097/aog.0b013e31827307b2

[16]

Ying "Antifungal susceptibility and molecular typing of 115 Candida albicans isolates obtained from vulvovaginal candidiasis patients in 3 Shanghai maternity hospitals" Med Mycol (2016) 10.1093/mmy/myv082

[17]

Brandolt "Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates" Braz J Microbiol (2017) 10.1016/j.bjm.2016.09.006

[18]

Fischer "Vulvovaginal candidiasis in postmenopausal women: the role of hormone replacement therapy" J Low Genit Tract Dis (2011) 10.1097/lgt.0b013e3182241f1a

[19]

Nyirjesy "Genital mycotic infections with canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus: a pooled analysis of clinical studies" Curr Med Res Opin (2014) 10.1185/03007995.2014.890925

[20]

Foxman "Candida vaginitis: self-reported incidence and associated costs" Sex Transm Dis (2000) 10.1097/00007435-200004000-00009

[21]

Lipsky "Impact of vaginal antifungal products on utilization of health care services: evidence from physician visits" J Am Board Fam Pract (2000) 10.3122/15572625-13-3-178

[22]

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

D. Moher, A. Liberati, J. Tetzlaff et al.

BMJ 2009 10.1136/bmj.b2535

[23]

What is “quality of evidence” and why is it important to clinicians?

Gordon H Guyatt, Andrew D Oxman, Regina Kunz et al.

BMJ 2008 10.1136/bmj.39490.551019.be

[24]

(2013)

[25]

Prevalence of Recurrent Vulvovaginal Candidiasis in 5 European Countries and the United States

Betsy Foxman, Ryan Muraglia, Jean-Paul Dietz et al.

Journal of Lower Genital Tract Disease 2013 10.1097/lgt.0b013e318273e8cf

[26]

Ferris "Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis" Obstet Gynecol (2002)

[27]

Ryan-Wenger "Accuracy of vaginal symptom self-diagnosis algorithms for deployed military women" Nurs Res (2010) 10.1097/nnr.0b013e3181c3b9dd

[28]

Sihvo "Self-medication with vaginal antifungal drugs: physicians' experiences and women's utilization patterns" Fam Pract (2000) 10.1093/fampra/17.2.145

[29]

Vergers-Spooren "Self-sampling in the diagnosis of recurrent vulvovaginal candidosis" J Low Genit Tract Dis (2013) 10.1097/lgt.0b013e31826009c3

[30]

Beigi "Vaginal yeast colonization in nonpregnant women: a longitudinal study" Obstet Gynecol (2004) 10.1097/01.aog.0000140687.51048.73

[31]

Sawyer "Vulvovaginal candidiasis in young women with cystic fibrosis" BMJ (1994) 10.1136/bmj.308.6944.1609

[32]

Pirotta "“Not thrush again!” Women's experience of post-antibiotic vulvovaginitis" Med J Aust (2003) 10.5694/j.1326-5377.2003.tb05418.x

[33]

Johnson "Attitudes and experience of women to common vaginal infections" J Low Genit Tract Dis (2010) 10.1097/lgt.0b013e3181d85bb7

[34]

Güzel "Candida vaginitis during contraceptive use: the influence of methods, antifungal susceptibility and virulence patterns" J Obstet Gynaecol (2013) 10.3109/01443615.2013.834306

[35]

(2014)

[36]

Vos "Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010" Lancet (2012) 10.1016/s0140-6736(12)61729-2

[37]

Emanuel "Sex and the single senior" The New York Times (New York) (2014)

[38]

Johnsson "Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin" J Diabetes Complications (2013) 10.1016/j.jdiacomp.2013.04.012

[39]

Nyirjesy "Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor" Curr Med Res Opin (2012) 10.1185/03007995.2012.697053

[40]

Lyon "Is genital Candida infection a significant problem for adults with cystic fibrosis?" J Cystic Fibrosis (2004)

[41]

Woolnough "Is candidiasis a problem in adults with cystic fibrosis? A prospective study" Thorax (2004)

[42]

Bluestein "Predicting the occurrence of antibiotic-induced candidal vaginitis (AICV)" Fam Pract Res J (1991)

[43]

Dennerstein "Oestrogen, glycogen and vaginal candidiasis" Aust NZJ Obstet Gynaecol (2001) 10.1111/j.1479-828x.2001.tb01238.x

[44]

Jolleys "A comparative study of prescribing of hormone replacement therapy in USA and Europe" Maturitas (1996) 10.1016/0378-5122(95)00952-3

[45]

Kent "Epidemiology of vaginitis" Am J Obstet Gynecol (1991) 10.1016/s0002-9378(12)90722-x

[46]

Vaca "High prevalence of bacterial vaginosis in adolescent girls in a tropical area of Ecuador" BJOG (2010) 10.1111/j.1471-0528.2009.02397.x

[47]

Mitchell "Measuring health-related productivity loss" Popul Health Manag (2011) 10.1089/pop.2010.0014

[48]

Nicholson "Measuring the effects of work loss on productivity with team production" Health Econ (2006) 10.1002/hec.1052

[49]

Donders "Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial)" Am J Obstet Gynecol (2008) 10.1016/j.ajog.2008.06.029

[50]

De Bernardis "A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models" Vaccine (2012) 10.1016/j.vaccine.2012.04.069

Showing 50 of 53 references

Cited By

520

Characterization of the vaginal microbiome and its metabolic potential in Colombian patients with recurrent vulvovaginal candidiasis

Jeiser Marcelo Consuegra-Asprilla, Yesid Cuesta-Astroz · 2026

Medical Mycology

Increasing rate of non-Candida albicansyeasts and fluconazole resistance in yeast isolates from women with recurrent vulvovaginal candidiasis in Leeds, United Kingdom

Jennifer C Ratner, Janet Wilson · 2024

Sexually Transmitted Infections

Candida albicans and Candida glabrata : global priority pathogens

Myrto Katsipoulaki, Mark H. T. Stappers · 2024

Microbiology and Molecular Biology...

Inflammatory cytokine signalling in vulvovaginal candidiasis: a hot mess driving immunopathology

Kar On Cheng, Dolly E Montaño · 2024

Oxford Open Immunology

Insights and advances in recurrent vulvovaginal candidiasis

Javier San Juan Galán, Vanessa Poliquin · 2023

PLOS Pathogens

In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China

Siyue Kan, Nana Song · 2022

Mycopathologia

Prevalence and species distribution of microorganisms isolated among non-pregnant women affected by vulvovaginal candidiasis: A retrospective study over a 20 year-period

Jari Intra, Maria Roberta Sala · 2022

Journal de Mycologie Médicale

Epidemiology, risk factors and antimicrobial profile of Vulvovaginal Candidiasis (VVC): A study among women in the central region of Saudi Arabia

D. Venugopal, K. Husain · 2021

Journal de Mycologie Médicale

Vulvovaginal candidiasis and current perspectives: new risk factors and laboratory diagnosis by using MALDI TOF for identifying species in primary infection and recurrence

Lívia Custódio Pereira, Amabel Fernandes Correia · 2021

European Journal of Clinical Microb...

Delivery strategies of amphotericin B for invasive fungal infections

Imran Shair Mohammad, Lifang Fan · 2021

Acta Pharmaceutica Sinica B

Recurrent Vulvovaginal Candidiasis: An Immunological Perspective

Diletta Rosati, Mariolina Bruno · 2020

Microorganisms

Metrics

520

Citations

53

References

Details

Published: Nov 01, 2018
Vol/Issue: 18(11)
Pages: e339-e347
License: View

Authors

Riina Rautemaa-Richardson

Cite This Article

David W Denning, Matthew Kneale, Jack D Sobel, et al. (2018). Global burden of recurrent vulvovaginal candidiasis: a systematic review. The Lancet Infectious Diseases, 18(11), e339-e347. https://doi.org/10.1016/s1473-3099(18)30103-8

Global burden of recurrent vulvovaginal candidiasis: a systematic review

You May Also Like